Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Animal models indicate that the antimicrobial peptide hepcidin (HAMP; OMIM 606464) is probably a key regulator of iron absorption in mammals. Here we report the identification of two mutations (93delG and 166C-->T) in HAMP on 19q13 in two families with a new type of juvenile hemochromatosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficits in hepcidin-mediated regulation of FPN, often due to hereditary hemochromatoses, lead to iron overload and widespread tissue damage affecting the liver, heart, pancreas, and joints 11-13 .”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [11]
In the citing paper
“There is a single human hepcidin gene whose essential role in iron homeostasis was confirmed by identifying homozygous frameshift or nonsense mutations in affected individuals with severe juvenile hemochromatosis”
From IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin (2004) · cites this paper as [9]
In the citing paper
“HAMP‐deficient mice and humans present with a severe iron loading phenotype, and injection of synthetic HAMP decreases serum iron concentrations. 39 , 40 , 41”
From The battle for iron in enteric infections (2020) · cites this paper as [40]
In the citing paper
“First, mutations in the hepcidin gene itself (called HAMP) cause hemochromatosis by preventing the production of functional hepcidin protein.161”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [161]
In the citing paper
“In iron-replete cells, IRP1, which has ∼30% homology to mitochondrial aconitase based on amino acid alignments, loses its affinity for the IRE, and converts to a cytosolic aconitase (127, 263).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [263]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Self-citationWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13468 · Cited by 561
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113468 · Cited by 557
Cited by
Items 201–300 of 869
New insights into the links between hypoxia and iron homeostasis
Renassia, C., & Peyssonnaux, C. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000494 · Cited by 99
Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice
Courselaud, B., Troadec, M., Fruchon, S., Ilyin, G., Borot, N., Leroyer, P., Coppin, H., Brissot, P., Roth, M., & Loréal, O. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2003.11.003 · Cited by 107
“The role of hepcidin in iron metabolism has been demonstrated in mice [4,7] and in humans [8].”
BackgroundHereditary hemochromatosis in the post- HFE era
Olynyk, J. K., Trinder, D., Ramm, G. A., Britton, R. S., & Bacon, B. R. (2008) · Hepatology · doi:10.1002/hep.22507 · Cited by 111
Ravia, J. J., Stephen, R. M., Ghishan, F. K., & Collins, J. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506727200 · Cited by 103
Hepcidin: A direct link between iron metabolism and immunity
Vyoral, D., & Petrák, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.02.023 · Cited by 95
Ferroptosis inhibition by oleic acid mitigates iron-overload-induced injury
Mann, J., Reznik, E., Santer, M., Fongheiser, M. A., Smith, N., Hirschhorn, T., Zandkarimi, F., Soni, R. K., Dafré, A. L., Miranda‐Vizuete, A., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.10.012 · Cited by 100
Interacting signals in the control of hepcidin expression
Darshan, D., & Anderson, G. J. (2009) · BioMetals · doi:10.1007/s10534-008-9187-y · Cited by 112
Molecular Diagnostic and Pathogenesis of Hereditary Hemochromatosis
Santos, P. C. J. L., Krieger, J. E., & Pereira, A. C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021497 · Cited by 98
“Types 2A (OMIM 602390) and 2B (OMIM 613313) are caused by mutations in HJV and HAMP genes, respectively [32,33].”
BackgroundGenetics of liver disease: From pathophysiology to clinical practice
Karlsen, T. H., Lammert, F., & Thompson, R. J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.025 · Cited by 95
“Furthermore, additional types of non-HFE hereditary haemochromatosis were subsequently described, linked to mutations in the ferroportin gene (SLC40A1) [17,18], the transferrin receptor 2 gene (TFR2) [19], the hepcidin gene (HAMP) [20] and the hemojuvelin gene (HJV) [21], respectively.”
BackgroundFerroportin1 is required for normal iron cycling in zebrafish
Fraenkel, P. G., Traver, D., Donovan, A., Zahrieh, D., & Zon, L. I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23780 · Cited by 93
“Although hepcidin expression has been found to be low in patients with hemochromatosis attributed to mutations in HFE (43), transferrin receptor 2 (44), hepcidin (45), or hemojuvelin (HFE2) (46), urinary protein levels have been found to be increased (47) in 2 hemochromatosis patients heterozygous for the Val162del mu…”
BackgroundMillard, K. N., Frazer, D. M., Wilkins, S. J., & Anderson, G. J. (2004) · Gut · doi:10.1136/gut.2003.031153 · Cited by 93
Bonkovsky, H. L., Naishadham, D., Lambrecht, R. W., Chung, R. T., Hoefs, J. C., Nash, S. R., Rogers, T. E., Banner, B. F., Sterling, R. K., Donovan, J. A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.036 · Cited by 97
Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease
Daher, R., Manceau, H., & Karim, Z. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.006 · Cited by 99
“The following two subtypes of type 2 HH have been reported: type 2A, which is caused by mutations in the HJV gene [54], and type 2B, which is associated with mutations in the HAMP gene [55].”
BackgroundMaisetta, G., Petruzzelli, R., Brancatisano, F. L., Esin, S., Vitali, A., Campa, M., & Batoni, G. (2010) · Peptides · doi:10.1016/j.peptides.2010.08.007 · Cited by 91
Nemeth, E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05585.x · Cited by 103
The function of heme-regulated eIF2α kinase in murine iron homeostasis and macrophage maturation
Liu, S., Suragani, R. N. V. S., Wang, F., Han, A., Zhao, W., Andrews, N. C., & Chen, J.-J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32084 · Cited by 103
“Disruption of hepcidin gene expression in mice (6, 7) and humans (8) resulted in iron overload, while overexpression of hepcidin in mice caused severe iron deficiency anemia (9).”
BackgroundMechanisms of Haem and Non-Haem Iron Absorption: Lessons from Inherited Disorders of Iron Metabolism
Anderson, G. J., Frazer, D. M., McKie, A. T., Vulpe, C. D., & Smith, A. (2005) · BioMetals · doi:10.1007/s10534-005-3708-8 · Cited by 112
“However, while patients carrying mutations in hemojuvelin or hepcidin show a similar histological pattern of iron distribution, they present with much more severe disease, usually in the second or third decade of life (Roetto et al. 2003; Papanikolaou et al. 2004).”
BackgroundProhepcidin accumulates in renal insufficiency
Taes, Y. E. C., Wuyts, B., Boelaert, J. R., Vriese, A. S. D., & Delanghe, J. R. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.069 · Cited by 89
“In humans, the role of hepcidin has been suggested by the presence of mutations in the hepcidin gene in two families with severe juvenile hemochromatosis (7) and by cases of refractory anemia associated with inappropriate expression of hepcidin in hepatic adenoma (8).”
BackgroundIron bioavailability: UK Food Standards Agency workshop report
Singh, M. K., Sanderson, P., Hurrell, R. F., Fairweather‐Tait, S. J., Geissler, C. A., Prentice, A., & Beard, J. L. (2006) · British Journal Of Nutrition · doi:10.1017/bjn20061894 · Cited by 98
Roetto, A. (2003) · Blood · doi:10.1182/blood-2003-10-3390 · Cited by 90
Self-citationThe molecular genetics of haemochromatosis
Gac, G. L., & Férec, C. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201490 · Cited by 99
The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1)
McKie, A. T., & Barlow, D. J. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1102-3 · Cited by 98
“TfR2 [5], Ireg1 (see below) and, recently, mutations in the stores regulator hepcidin [33] have been found to be responsible for a severe form of haemochromatosis (juvenile haemochromatosis).”
HFE-Related Hemochromatosis: An Update for the Rheumatologist
Husar-Memmer, E., Stadlmayr, A., Datz, C., & Zwerina, J. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0393-4 · Cited by 94
Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
Nemeth, E. (2010) · Advances in Hematology · doi:10.1155/2010/750643 · Cited by 86
Iron disorders of genetic origin: a changing world
Brissot, P., Bardou‐Jacquet, E., Jouanolle, A., & Loréal, O. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.004 · Cited by 92
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease
Panwar, B., & Gutiérrez, O. M. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.002 · Cited by 98
“On the other hand, hepcidin deficiency can lead to excessive iron absorption and iron overload disorders, the basis of several forms of hereditary hemochromatosis.(33)”
BackgroundFabio, G., Minonzio, F., Delbini, P., Bianchi, A., & Cappellini, M. D. (2006) · Blood · doi:10.1182/blood-2006-04-016949 · Cited by 87
Conditional deletion of ferritin H in mice induces loss of iron storage and liver damage #
Darshan, D., Vanoaica, L., Richman, L., Beermann, F., & Kühn, L. C. (2009) · Hepatology · doi:10.1002/hep.23058 · Cited by 86
Molecular Mechanisms and Regulation of Iron Transport
Chung, J., & Wessling‐Resnick, M. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609332 · Cited by 100
A Novel Immunological Assay for Hepcidin Quantification in Human Serum
Koliaraki, V., Marinou, M., Vassilakopoulos, T. P., Vavourakis, E., Tsochatzis, E. A., Pangalis, G. A., Papatheodoridis, G., Stamoulakatou, A., Swinkels, D. W., Papanikolaou, G. V., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004581 · Cited by 93
“Furthermore, hepcidin in hemojuvelin (HJV) associated juvenile hemochromatosis is downregulated [8,9].”
BackgroundSelf-citationRegulators of hepcidin expression
Roth, M., Meynard, D., & Coppin, H. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.005 · Cited by 97
Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice
Utzschneider, K. M., & Kowdley, K. V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.241 · Cited by 94
Hepcidin is a key mediator of anemia of inflammation in Crohn's disease
Basseri, R. J., Nemeth, E., Vassilaki, M. E., Basseri, B., Enayati, P. J., Shaye, O. A., Bourikas, L. A., Ganz, T., & Papadakis, K. A. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.10.013 · Cited by 86
A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient
Arden, K. E., Wallace, D. F., Dixon, J. L., Summerville, L., Searle, J. W., Anderson, G. J., Ramm, G. A., Powell, L. W., & Subramaniam, V. N. (2003) · Gut · doi:10.1136/gut.52.8.1215 · Cited by 84
Silvestri, L., Pagani, A., Fazi, C., Gerardi, G., Levi, S., Arosio, P., & Camaschella, C. (2007) · Blood · doi:10.1182/blood-2006-08-041004 · Cited by 84
Self-citationRegulation of Hepcidin by Erythropoiesis: The Story So Far
Pasricha, S., McHugh, K., & Drakesmith, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050731 · Cited by 92
“Hepcidin knockout mice, and sporadic cases of humans with mutations in the hepcidinencoding HAMP gene, exhibit marked iron overload (47, 76).”
BackgroundWallace, D. F., Clark, R. M., Harley, H. A. J., & Subramaniam, V. N. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.008 · Cited by 83
Biasiotto, G., Belloli, S., Ruggeri, G., Zanella, I., Gerardi, G., Corrado, M., Gobbi, E., Albertini, A., & Arosio, P. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023440 · Cited by 83
“Another form of HH, with earlier symptomatic presentation and more severe clinical course, was found associated with rare homozygous disabling mutations of the hepcidin gene (OMIM 606464) on chromosome 19 ( 14 ). Two Mediterranean pedigrees have been described that carry the mutations R56X and 93delG.”
BackgroundZumbrennen‐Bullough, K. B., & Babitt, J. L. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft443 · Cited by 92
“Among these genes, HJV has the most critical role in hepcidin regulation since HJV mutations lead to the more severe juvenile onset form of hemochromatosis that is similar to the phenotype seen with mutations in hepcidin itself [21, 38].”
BackgroundThe European Hematology Association Roadmap for European Hematology Research: a consensus document
Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Dohner, H., de Wit, T. D., Eichinger, S., Fibbe, W., Green, T., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136739 · Cited by 81
Pathophysiological consequences and benefits of HFE mutations: 20 years of research
Hollerer, I., Bachmann, A., & Muckenthaler, M. U. (2017) · Haematologica · doi:10.3324/haematol.2016.160432 · Cited by 99
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis
Girelli, D., Trombini, P., Busti, F., Campostrini, N., Sandri, M. F., Pelucchi, S., Westerman, M., Ganz, T., Nemeth, E., Piperno, A., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.033449 · Cited by 81
Self-citationHepatocyte-targeted HFE and TFR2 control hepcidin expression in mice
Gao, J., Chen, J., Domenico, I. D., Koeller, D. M., Harding, C. O., Fleming, R. E., Koeberl, D. D., & Enns, C. A. (2010) · Blood · doi:10.1182/blood-2009-09-245209 · Cited by 87
Viatte, L., Nicolas, G., Lou, D.-Q., Bennoun, M., Lesbordes, J.-C., Canonne‐Hergaux, F., Schönig, K., Bujard, H., Kahn, A., Andrews, N. C., et al. (2005) · Blood · doi:10.1182/blood-2005-10-4071 · Cited by 87
Hereditary iron overload: Update on pathophysiology, diagnosis, and treatment
Franchini, M. (2006) · American Journal of Hematology · doi:10.1002/ajh.20493 · Cited by 92
“In fact, besides the evidence that an hepcidin deficiency causes a severe iron overload in animals and is associated in humans with a severe type of juvenile hemochromatosis [34,39], it has been demonstrated that mice and humans with homozygous HFE-related hemochromatosis have inappropriately low hepatic expression an…”
BackgroundWeizer‐Stern, O., Adamsky, K., Amariglio, N., Levin, C., Koren, A., Breuer, W., Rachmilewitz, E., Breda, L., Rivella, S., Ioav Cabantchik, Z., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06258.x · Cited by 80
“Mutations in the HAMP gene were identified in families with severe juvenile haemochromatosis (Roetto et al, 2003) while hepatic adenomas overexpressing hepcidin were described in patients with severe iron refractory anaemia (Weinstein et al, 2002).”
BackgroundMatthes, T., Aguilar‐Martinez, P., Pizzi-Bosman, L., Darbellay, R., Rubbia‐Brandt, L., Giostra, E., Michel, M., Ganz, T., & Beris, P. (2004) · Blood · doi:10.1182/blood-2004-01-0332 · Cited by 87
Robertson, L. S., Iwanowicz, L. R., & Marranca, J. M. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.03.023 · Cited by 87
Hepcidin: Homeostasis and Diseases Related to Iron Metabolism
Reichert, C. O., da Cunha, J., Levy, D., Maselli, L. M. F., Bydlowski, S. P., & Spada, C. (2017) · Acta Haematologica · doi:10.1159/000471838 · Cited by 85
Ethnic Differences in Iron Status
Kang, W., Barad, A., Clark, A. G., Wang, Y., Xu, L., Gu, Z., & O'Brien, K. O. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab035 · Cited by 77
Lipiński, P., Styś, A., & Starzyński, R. R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1018-1 · Cited by 84
“Affected individuals suffer from a juvenile hereditary hemochromatosis, which confirms that hepcidin is also an important molecule in human iron homeostasis [11].”
BackgroundMleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515957 · Cited by 74
“Hereditary hemochromatosis (HH) is caused by inappropriately low hepcidin levels(1) and has been linked to loss-of-function mutations in the hepcidin-activating genes HFE,(3) transferrin receptor 2 (TfR2),(4) and hemojuvelin (HJV),(5) or in hepcidin itself.(6) Despite the high prevalence of mutations in the HFE gene,…”
BackgroundHepcidin: the Missing Link between Hemochromatosis andInfections
Ashrafian, H. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.6693-6700.2003 · Cited by 74
“Recently, a genetic approach was able to associate mutations in the hepcidin antimicrobial peptide (HAMP) encoded on chromosome 19q13, a key regulator of iron metabolism, with type 2 juvenile hemochromatosis (62).”
BackgroundMok, H., Jelinek, J., Pai, S., Cattanach, B. M., Prchal, J. T., Youssoufian, H., & Schumacher, A. (2004) · Development · doi:10.1242/dev.01081 · Cited by 73
“…weeks of age Recent studies in mice and individuals with juvenile hemochromatosis have implicated Hamp as the hormonal regulator of iron homeostasis (Nicolas et al., 2001; Park et al., 2001; Pigeon et al., 2001; Nicolas et al., 2002a; Ahmad et al., 2002; Nicolas et al., 2003; Roetto et al., 2003).”
BackgroundAguilar‐Martinez, P., Schved, J., & Brissot, P. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40998.x · Cited by 76
“In humans, this type of JH was at first described in an Italian family (51) and seems to be relatively rare.”
BackgroundIsland, M., Jouanolle, A., Mosser, A., Deugnier, Y., David, V., Brissot, P., & Loréal, O. (2009) · Haematologica · doi:10.3324/haematol.2008.001784 · Cited by 76
Limdi, J. K., & Crampton, J. R. (2004) · QJM · doi:10.1093/qjmed/hch065 · Cited by 88
Iron homeostasis: new players, newer insights
Edison, E. S., Bajel, A. R., & Chandy, M. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01143.x · Cited by 88
Catapano, A., Cimmino, F., Petrella, L., Pizzella, A., D’Angelo, M., Ambrosio, K., Marino, F., Sabbatini, A., Petrelli, M. D., Paolini, B., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109888 · Cited by 80
Molecular mechanism of intestinal iron absorption
Han, O. (2011) · Metallomics · doi:10.1039/c0mt00043d · Cited by 90
Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression
Theurl, M., Theurl, I., Hochegger, K., Obrist, P., Subramaniam, N., van Rooijen, N., Schuemann, K., & Weiss, G. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0346-y · Cited by 69
“Hepcidin overexpression results in reduced duodenal iron absorption and subsequent development of anemia, while hepcidin depletion causes iron overload [3–6].”
BackgroundEnns, C. A., Ahmed, R., Wang, J., Ueno, A., Worthen, C., Tsukamoto, H., & Zhang, A.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060534 · Cited by 69
“In contrast, lack of hepcidin causes juvenile hemochromatosis [4], a particularly severe form of iron overload [2,5,6,7].”
BackgroundInterplay Between Iron Overload and Osteoarthritis: Clinical Significance and Cellular Mechanisms
Cai, C., Hu, W., & Chu, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.817104 · Cited by 80
“It has also been observed that other subtypes of HH can be caused by mutations in the hepcidin antimicrobial peptide (HAMP) gene-encoding hepcidin or the main inducer genes (such as HFE, transferrin receptor-2 gene (TfR2), and hemojuvelin gene (HJV)) associated with hepcidin expression (Camaschella et al., 2000; Roett…”
BackgroundPietrangelo, A., & Trautwein, C. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0019 · Cited by 78
“In fact, lack of hepcidin leads to a severe form of juvenile hereditary hemochromatosis”
BackgroundKrijt, J., Vokurka, M., Chang, K., & Nečas, E. (2004) · Blood · doi:10.1182/blood-2004-06-2422 · Cited by 74
Revisiting hemochromatosis: genetic vs. phenotypic manifestations
Anderson, G. J., & Bardou‐Jacquet, E. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5512 · Cited by 70
“Mutations in two genes have been found to lead to juvenile hemochromatosis, HFE2, the gene encoding hemojuvelin (HJV) (type 2A) and HAMP, which encodes hepcidin itself (type 2B) (67,68).”
BackgroundIron and liver cancer: an inseparable connection
Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 75
Neogenin Interacts with Matriptase-2 to Facilitate Hemojuvelin Cleavage
Enns, C. A., Ahmed, R., & Zhang, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363937 · Cited by 76
Luque‐Ramírez, M., Álvarez‐Blasco, F., Alpañés, M., & Escobar-Morreale, H. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2211 · Cited by 73
Lombardi, L., Maisetta, G., Batoni, G., & Tavanti, A. (2015) · Molecules · doi:10.3390/molecules20046319 · Cited by 71
“It is known that mutations in the human hep-25 gene are related with pathologies such as human hereditary hemochromatosis [47], indicating that this peptide plays a prominent role in the regulation of iron concentration.”
BackgroundLatour, C., Besson‐Fournier, C., Meynard, D., Silvestri, L., Gourbeyre, O., Aguilar‐Martinez, P., Schmidt, P. J., Fleming, M. D., Roth, M., & Coppin, H. (2015) · Hepatology · doi:10.1002/hep.28254 · Cited by 71
“More rare forms of HH result from mutations in the genes encoding TfR2,(4) hemojuvelin (HJV),(5) or hepcidin.(6) All the proteins mutated in HH are expressed at high levels in the liver and are involved in regulating the expression of hepcidin, a small peptide hormone secreted by the liver in response to iron loading.”
BackgroundWahedi, M., Wortham, A. M., Kleven, M. D., Zhao, N., Jue, S. F., Enns, C. A., & Zhang, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.801795 · Cited by 72
“Lack of hepcidin causes juvenile hemochromatosis, a severe form of iron overload disorder (4).”
BackgroundPathophysiology of Hereditary Hemochromatosis
Fleming, R. E., Britton, R. S., Waheed, A., Sly, W. S., & Bacon, B. R. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923313 · Cited by 76
Is Hepcidin a Link between Anemia, Inflammation and Liver Function in Hemodialyzed Patients?
Małyszko, J., Małyszko, J. S., Hryszko, T., Pawlak, K., & Myśliwiec, M. (2005) · American Journal of Nephrology · doi:10.1159/000089266 · Cited by 72
Haemochromatosis: The bone and the joint
Guggenbuhl, P., Brissot, P., & Loréal, O. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.014 · Cited by 69
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA)
Falco, L. D., Totaro, F., Nai, A., Pagani, A., Girelli, D., Silvestri, L., Piscopo, C., Campostrini, N., Dufour, C., Almanjomi, F., et al. (2010) · Human Mutation · doi:10.1002/humu.21243 · Cited by 68
Self-citationRamsay, A. J., Quesada, V., Sánchez, M., Garabaya, C., Sardà, M. P., Baiget, M., Remacha, A. F., Velasco, G., & López-Otín, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp315 · Cited by 70
“In accordance with its role in coordinating body iron levels, alterations in the genes encoding hepcidin (19) or its key regulators (20–22) induce iron overload syndromes such as hereditary hemochromatosis (HH).”
BackgroundCis and trans regulation of hepcidin expression by upstream stimulatory factor
Bayele, H. K., McArdle, H. J., & Srai, S. K. (2006) · Blood · doi:10.1182/blood-2005-07-027037 · Cited by 78
“A frame-shift mutation identified in the human hepcidin gene has also been associated with a juvenile form of haemochromatosis.(15) This peptide also appears to control iron trafficking by binding to and post-translationally modulating ferroportin levels.”
BackgroundTruksa, J., Gelbart, T., Peng, H., Beutler, E., Beutler, B., & Lee, P. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07873.x · Cited by 72
“The severe phenotype has been attributed to mutations in genes encoding hemojuvelin (HFE2) or hepcidin (HAMP) resulting in loss of hepcidin expression (Roetto et al, 2003; Papanikolaou et al, 2004).”
BackgroundSex and Acquired Cofactors Determine Phenotypes of Ferroportin Disease
Lan, C. L., Mosser, A., Ropert, M., Détivaud, L., Loustaud-Ratti, V., Vital-Durand, D., Roget, L. D.-P., Bardou‐Jacquet, E., Turlin, B., David, V., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.049 · Cited by 67
Transferrin-a modulates hepcidin expression in zebrafish embryos
Fraenkel, P. G., Gibert, Y., Holzheimer, J., Lattanzi, V. J., Burnett, S. F., Dooley, K. A., Wingert, R. A., & Zon, L. I. (2008) · Blood · doi:10.1182/blood-2008-06-165340 · Cited by 69
Hereditary Hemochromatosis Restores the Virulence of Plague Vaccine Strains
Quenee, L. E., Hermanas, T. M., Ciletti, N., Louvel, H., Miller, N. C., Elli, D., Blaylock, B., Mitchell, A., Schroeder, J., Krausz, T., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis433 · Cited by 65
“Five genes have been associated with disease, including HFE [29], TRF2 (transferrin receptor2) [30], SLC40A1 (ferroportin) [31], HAMP (hepcidin) [32],”
BackgroundCHEN, B., Li, G., Shen, Y., Huang, X., & Xu, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2484 · Cited by 68
Kawabata, H. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2365-3 · Cited by 68
“Moreover, another type of very severe juvenile HH caused by mutations of HAMP which encodes hepcidin was reported (HH type 2B, Table 1) [11].”
BackgroundGenetic iron overload disorders
Corradini, E., Buzzetti, E., & Pietrangelo, A. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100896 · Cited by 69
Leung, P. S., Srai, S. K., Mascarenhas, M., Churchill, L. J., & Debnam, E. S. (2005) · Gut · doi:10.1136/gut.2004.062083 · Cited by 66
Molecular basis of iron-loading disorders
Darshan, D., Frazer, D. M., & Anderson, G. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001687 · Cited by 70
Bastos, P. A. D., Trindade, F., da Costa, J. P., Ferreira, R. M., & Vitorino, R. M. P. (2017) · Medicinal Research Reviews · doi:10.1002/med.21435 · Cited by 67
BMP6 orchestrates iron metabolism
Camaschella, C. (2009) · Nature Genetics · doi:10.1038/ng0409-386 · Cited by 72
Self-citationIdentification of a novel mutation (C321X) in HJV
Huang, F. W., Rubio‐Aliaga, I., Kushner, J. P., Andrews, N. C., & Fleming, M. D. (2004) · Blood · doi:10.1182/blood-2004-01-0400 · Cited by 63
McCune, C. A., Ravine, D., Carter, K., Jackson, H. A., Hutton, D., Hedderich, J., Krawczak, M., & Worwood, M. (2005) · Gut · doi:10.1136/gut.2005.070342 · Cited by 65
Lou, D., Lesbordes, J., Nicolas, G., Viatte, L., Bennoun, M., Van Rooijen, N., Kahn, A., Renia, L., & Vaulont, S. (2005) · Hepatology · doi:10.1002/hep.20663 · Cited by 62
The molecular basis of iron overload disorders and iron-linked anemias
Kaplan, J., Ward, D. M., & Domenico, I. D. (2011) · International Journal of Hematology · doi:10.1007/s12185-010-0760-0 · Cited by 69
“These include the structural gene for hepcidin HAMP [ 24 ] and genes that are required for expression of hepcidin, hemojuvelin, transferrin receptor 2 and HFE.”
BackgroundWhole Genome Expression Differences in Human Left and Right Atria Ascertained by RNA Sequencing
Hsu, J., Hanna, P., Wagoner, D. R. V., Barnard, J., Serre, D., Chung, M. K., & Smith, J. D. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961631 · Cited by 66
Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease†
Zoller, H., McFarlane, I., Theurl, I., Stadlmann, S., Nemeth, E., Oxley, D., Ganz, T., Halsall, D. J., Cox, T. M., & Vogel, W. (2005) · Hepatology · doi:10.1002/hep.20775 · Cited by 69
Hepcidin: an important new regulator of iron homeostasis
Hugman, A. (2006) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2006.00768.x · Cited by 76
“…to be low in patients with HJV mutations (Papanikolaou et al., 2004) and there are case reports linking hepcidin mutations with JH in three families (Roetto et al., 2003; Matthes et al., 2004) The hepcidin gene was sequenced in patients from 21 families regardless of linkage with chromosome 1q and…”
BackgroundRecent advances in understanding haemochromatosis: a transition state
Robson, K., Merryweather-Clarke, A. T., Cadet, E., Viprakasit, V., Zaahl, M. G., Pointon, J. J., Weatherall, D. J., & Rochette, J. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020644 · Cited by 70
Sandhu, K., Flintoff, K., Chatfield, M. D., Dixon, J. L., Ramm, L. E., Ramm, G. A., Powell, L. W., Subramaniam, V. N., & Wallace, D. F. (2018) · Blood · doi:10.1182/blood-2018-02-830562 · Cited by 61
HJV gene mutations in European patients with juvenile hemochromatosis
Gehrke, S. G., Pietrangelo, A., Kascak, M., Braner, A., Eisold, M., Kulaksiz, H., Herrmann, T. R. W., Hebling, U., Bents, K., Gugler, R., et al. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00413.x · Cited by 61
“Molecular studies did not reveal any mutation within the HAMP gene.”
BackgroundInfluentialCellular sensing and transport of metal ions: implications in micronutrient homeostasis
Bird, A. J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.002 · Cited by 66
“In support of hepcidin playing a central role in the control of systemic iron levels, mutations in HAMP lead to the juvenile-onset form of the genetic iron overload disorder hereditary hemochromatosis [105].”
Background
Metadata
- Authors
- Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- National and Kapodistrian University of Athens (GR)
- University of Verona (IT)
- Theageneio General Hospital (GR)
- Corresponding author
- Camaschella, Clara
- ORCID
- Venue
- Nature Genetics
- Published
- 2002-12-09
- Volume
- 33
- Issue
- 1
- Pages
- 21-22
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2056282179
- Cited by
- 860
- References
- 16
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 23 · 2019: 14 · 2018: 19 · 2017: 35 · 2016: 23 · 2015: 32 · 2014: 28 · 2013: 37 · 2012: 37
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- hepcidin, juvenile hemochromatosis, antimicrobial peptides, iron absorption regulation, 19q13, hereditary hemochromatosis
- MeSH terms
- Amino Acid Sequence, Base Sequence, Child, DNA Mutational Analysis, Female, Hemochromatosis, Humans, Male, Molecular Sequence Data, Mutation, Pedigree, Polymorphism, Single-Stranded Conformational, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.